Wound Management 2005

[Please note: The report described below is the subject of report #S245,
"Worldwide Wound Management, 2005-2014:
Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan & Rest of World,"
published November 2007. See Report #S245.]

Worldwide Wound Management, 2005-2014:
Established and Emerging Products, Technologies and Markets
in the U.S., Europe, Japan and Rest of World

· 304 pages · 47 Exhibits · 67 Company Profiles · Pub. Date August 2005 · Report #S225

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

[Note: The subtopic of surgical sealants, glues and wound closure has been addressed in the separate MedMarket Diligence report #S122.]

EXECUTIVE SUMMARY

Section 1: BACKGROUND

1.1       Industry Structure

1.2       A Complex Industry

1.3       Major Wound Management Corporations

1.4       Historical Perspective and Technology Breakthroughs

1.5       World-Wide Regulatory and Reimbursement Environment

1.5.1          Cost Effectiveness

1.5.2          Clinical

1.5.3          Regulatory

1.5.4          Reimbursement

1.5.4.1       U.S.A.

1.5.4.2       European Union

1.5.4.3       France

1.5.4.4       Germany

1.5.4.5       United Kingdom

1.5.4.6       Italy

1.5.4.7       Belgium

1.5.4.8       Spain

1.5.4.9       Scandinavia

1.6       Geographical Differences in Treatments of Wounds

1.7       Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence

1.8       Wound Management Trends

1.8.1          Surgical Wounds

1.8.2          Traumatic Wounds

1.8.3          Burns

1.8.4          Chronic Wounds

1.9       Market Dynamics

Section 2: CLINICAL BACKGROUND AND CASELOAD

2.1       Background

2.2       Wound Types

2.2.1          Classification By Severity

2.2.2          Classification By Morphology

2.2.3          Classification By Etiology

2.2.3.1       Surgical Wounds

2.2.3.2       Traumatic Wounds

2.2.3.3       Burns

2.2.3.4       Pressure Ulcers

2.2.3.5       Venous Ulcers

2.2.3.6       Arterial Ulcers

2.2.3.7       Diabetic Ulcers

2.2.3.8       Amputations

2.2.3.9       Abnormal Scarring

2.2.3.10     Acquired Immunodeficiency Syndrome

2.3       Wound Healing Physiology

2.3.1          Inflammatory Phase

2.3.2          Proliferative Phase

2.3.3          Maturation Phase

2.3.4          Factors Affecting Wound Healing

2.3.5          Extrinsic Factors

2.3.6          Mechanical Stress

2.3.7          Debris

2.3.8          Temperature

2.3.9          Desiccation and Maceration

2.3.10        Infection

2.3.11        Chemical Stress

2.3.12        Medication

2.3.13        Other Extrinsic Factors

2.3.14        Intrinsic Factors

2.3.15        Health Status

2.3.16        Age Factors

2.3.17        Body Build

2.3.18        Nutritional Status

2.4       Major Treatment Categories and Regimes

2.5       Incidence of Treatments, Growth Rates and Trends

Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS

3.1       Background

3.2       Film Dressings

3.2.1          Overview

3.2.2          Product Examples

3.2.3          Market and Competitive Activity

3.3       Hydrocolloids

3.3.1          Overview

3.3.2          Product Examples

3.3.3          Market and Competitive Activity

3.4       Foam Dressings

3.4.1          Overview

3.4.2          Product Examples

3.4.3          Market and Competitive Activity

3.5       Alginate Dressings

3.5.1          Overview

3.5.2          Product Examples

3.5.3          Market and Competitive Activity

3.6       Hydrogels

3.6.1          Overview

3.6.2          Product Examples

3.6.3          Market and Competitive Activity

3.7       Non Adherent Dressings

3.7.1          Overview

3.7.2          Product Examples

3.7.3          Market and Competitive Activity

3.8       Antimicrobial Dressings

3.8.1          Overview

3.8.2          Product Examples

3.8.3          Market and Competitive Activity

3.9       Tissue Engineered Products

3.9.1          Overview

3.9.2          Product Examples

3.9.3          Market and Competitive Analysis

3.10     Pharmacological Products

3.10.1        Overview

3.10.2        Product Examples

3.10.2.1     Growth Factors

3.10.2.2     Non-Growth Factor Modulators

3.10.2.3     Gene Therapy

3.10.3        Market and Competitive Analysis

3.10.3.1     Growth Factors

3.10.3.2     Non-Growth Factor Stimulants

3.10.3.3     Gene Therapy

3.11     Physical Treatments

3.11.1        Overview

3.11.2        Product Examples

3.11.2.1     Pressure Devices

3.11.2.2     Hydrotherapy

3.11.2.3     Electrical Stimulation

3.11.2.4     Electromagnetic Stimulation Devices

3.11.2.5     Ultraviolet Therapy

3.11.2.6     Hyperbaric Oxygen Therapy

3.11.2.7     Mechanically Assisted Wound Closure Devices

3.11.2.8     Ultrasound Devices

3.11.2.9     Laser Devices

3.11.2.10   Wound Imaging/Documentation

3.11.3        Market and Competitive Analysis

3.11.3.1     Pressure Devices

3.11.3.2     Hydrotherapy

3.11.3.3     Electrical Stimulation

3.11.3.4     Hyperbaric Oxygen Therapy

3.11.3.5     Mechanically Assisted Wound Closure Devices

3.11.3.6     Lasers

Section 4: Country Market Analysis

4.1       Global Overview

4.1.1          Market Estimates

4.1.2          Market potential

4.1.3          Leading Wound Care Companies

4.1.4          Leading National Markets

4.2       USA

4.2.1          Market Opportunity

4.2.2          Market for Advanced Wound Management Products

4.3       Japan

4.3.1          Wound Care Market

4.3.2          Market Opportunity

4.3.3          Leading Companies

4.4       Germany

4.4.1          Wound Care Market

4.4.2          Leading Companies

4.5       France

4.5.1          Wound Care Market

4.5.2          Leading Companies

4.6       Italy

4.6.1          Wound Care Market

4.6.2          Leading Companies

4.7       United Kingdom

4.7.1          Wound Care Market

4.7.2          Leading Companies

Section 5: COMPANY PROFILES

5.1       Major Companies

5.1.1          Bertek Pharmaceuticals (Mylan Labs.)

5.1.2          Carrington Laboratories Inc.

5.1.3          Coloplast Group

5.1.4          ConvaTec Inc.

5.1.5          Derma Sciences Inc.

5.1.6          DeRoyal Industries Inc.

5.1.7          Ethicon (Johnson & Johnson)

5.1.8          Gentell Inc.

5.1.9          Geritrex Corp.

5.1.10        Hartmann Group

5.1.11        Hollister Incorporated

5.1.12        Lohmann and Rauscher International GmbH and Co. KG

5.1.13        Medline

5.1.14        3M Group

5.1.15        Mölnlycke AB

5.1.16        Smith and Nephew Group

5.1.17        Tyco International Ltd.

5.2       Specialist Companies

5.2.1          Antimicrobial Dressings

5.2.1.1       Acrymed Inc.

5.2..1.2      Argentum Products LLC

5.2.2          Oxygen Therapy

5.2.2.1       Perry Baromedical Corp.

5.2.3          Skin Substitutes

5.2.3.1       BioTissue Technologies AG

5.2.3.2       Fidia Group

5.2.3.3       Genzyme Biosurgery

5.2.3.4       Innogenetics

5.2.3.5       Integra Life Sciences Inc.

5.2.3.6       IsoTis S.A

5.2.3.7       Modex Therapeutics

5.2.3.8       Organogenesis Inc.

5.2.3.9       Ortec International Inc.

5.2.4          Hydrogels

5.2.4.1       Hydromer Inc.

5.2.5          Growth Factors

5.2.5.1       E.S. Cell International

5.2.6          Odour Control

5.2.6.1       CliniMed

5.2.7          Other Therapeutic Modalities

5.2.7.1       Anodyne Therapy LLC

5.2.7.2       Augustine Medical Inc./Arizant, Inc.

5.2.7.3       BioMedical Life Systems Inc

5.2.7.4       BlueSky Medical Group

5.2.7.5       Diapulse Corp of America

5.2.7.6       Electromedical Products International Inc.

5.2.7.7       Globalcare Medical

5.2.7.8       Kinetic Concepts Inc.

5.2.7.9       Koldcare

5.2.7.10     Microvas Technologies

5.2.7.11     Regenesis Biomedical Inc.

5.2.7.12     Roho Inc.

5.2.8          Summary Profiles

5.2.8.1       AciesHealth

5.2.8.2       Bard Medical Division

5.2.8.3       Biocore Medical Technologies Inc.

5.2.8.4       Biomarin Pharmaceuticals Inc.

5.2.8.5       Brennen Medical Inc.

5.2.8.6       Dermacor Inc.

5.2.8.7       Derma Rite Industries LLC

5.2.8.8       Encelle Inc.

5.2.8.9       Ferris Manufacturing Corp.

5.2.8.10     Fibrogen

5.2.8.11     Geistlich Pharma

5.2.8.12     HemCon Inc

5.2.8.13     Hymed Group Corporation

5.2.8.14     Integra Life Sciences Holdings Corp.

5.2.8.15     Laboratoires Urgo

5.2.8.16     L.A.M. Pharmaceutical Corp.

5.2.8.17     Lifewave Ltd

5.2.8.18     Longport Inc.

5.2.8.19     Microban International Ltd

5.2.8.20     Maersk Medical

5.2.8.21     Nagor Ltd.

5.2.8.22     SSL International Plc

5.2.8.23     Swiss American Products, Inc.

Exhibit 1-3: Active Wound Management Products, Worldwide Market Forecast, 2005-2014

Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2005-2014

Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2005

Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2005-2014

Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2005-2014

Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category

Exhibit 3-29: Mechanically-Assisted Wound Closure, Worldwide Market Forecast, 2005-2014

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2005-2014

Exhibit 4-4: Forecast U.S. Sales for the Main Tpes of Advanced Wound Management Products for the Period 2005-2014

Exhibit 4-5: Japanese Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014

Exhibit 4-6: German Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014

Exhibit 4-7: French Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014

Exhibit 4-8: Italian Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014

Exhibit 4-9: UK Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014

[Please note: The report described below is the subject of report #S245, "Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World,"
published November 2007. See Report #S245.]

Worldwide Wound Management, 2005-2014: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan & Rest of World